SC
XBI icon

Searle & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Searle & Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,000
Closed -$556K – 190
2024
Q2 		$556K Buy
+6,000
New +$538K 0.13% 106

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Searle & Co's XBI Position: Q3 2024 in Review

Searle & Co sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 6,000 shares — an estimated $556K sold.

Searle & Co first reported a position in XBI in Q2 2024 and held it in 1 quarter. The position peaked at $556K in Q2 2024. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Searle & Co reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • Searle & Co sold 6,000 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $556K.
  • Searle & Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and held it in 1 quarter.
  • Searle & Co's State Street SPDR S&P Biotech ETF position peaked at $556K in Q2 2024.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Searle & Co's 13F filing for Q3 2024, filed 22 Oct 2024.